Antigenic determinants of asthma-associated allergens for design of immunotherapy Project Summary/Abstract Allergic reactions to cockroach and dust mite are important health problems in the U.S. affecting up to 83% of asthmatic children in inner city areas and are a risk factor for emergency room admission with asthma. The main cockroach species in the U.S., Blattella germanica, produces Bla g 2 which induces sensitization at exposure levels 10-100 times lower than cat and mite allergens, and has the highest prevalence of sensitization among cockroach allergens (40-70%). Der p 1 and Der f 1 are cysteine proteases produced by the dust mites Dermatophagoides pteronyssinus and D. farinae, respectively. IgE sensitization to these Group 1 allergens is >80% among mite allergic patients. Proteolytic activity of Der p 1 may enhance IgE antibody production and contribute to lung inflammation in asthma but Bla g 2 is an inactive aspartic protease- homolog. The main goal of this project is to investigate the antigenic structure of proteolytic (mite Group 1) and non-proteolytic (Bla g 2) allergens associated with asthma. Allergens will be co-crystallized with monoclonal antibodies, and the key amino acids involved in antibody (IgE and mAb) binding will be identified. Alternatively, identification of IgE antibody binding epitopes will be performed by phage display technology.
The specific aims are: 1) mapping of antigenic determinants in Bla g 2 by crystallography;2) mapping of antigenic determinants of Group 1 mite allergens by crystallography and analysis of the structural basis for the cross-reactivity between Der p 1 and Der f 1;and 3) localization of the key amino acids involved in the antibody binding epitopes by site-directed mutagenesis studies and identification of hypoallergenic mutants with T cell reactivity that could be used for immunotherapy. IgE antibody binding to the epitope mutants will be analyzed by ELISA, multiplex array technology and cell mediator release assays. Mutants will be compared to select hypoallergenic forms for the design of vaccines for immunotherapy of mite and cockroach allergy.

Public Health Relevance

Cockroach and mite allergy is associated with the development of asthma, which affects 17 million people in the U.S. The antigenic determinants of Bla g 2 and Group 1 mite allergens will be identified to elucidate the importance of the intrinsic properties of these allergens on allergic disease. Hypoallergenic mutants will be produced and tested for IgE antibody binding and T cell proliferation, and the information obtained will facilitate a rational design of allergy vaccines.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI077653-03
Application #
8132855
Study Section
Hypersensitivity, Autoimmune, and Immune-mediated Diseases Study Section (HAI)
Program Officer
Minnicozzi, Michael
Project Start
2009-08-25
Project End
2013-07-31
Budget Start
2011-08-01
Budget End
2012-07-31
Support Year
3
Fiscal Year
2011
Total Cost
$453,321
Indirect Cost
Name
Indoor Biotechnologies
Department
Type
DUNS #
007370633
City
Charlottesville
State
VA
Country
United States
Zip Code
22903
Pomés, Anna; Mueller, Geoffrey A; Randall, Thomas A et al. (2017) New Insights into Cockroach Allergens. Curr Allergy Asthma Rep 17:25
Ogburn, Ryenne N; Randall, Thomas A; Xu, Yingrong et al. (2017) Are dust mite allergens more abundant and/or more stable than other Dermatophagoides pteronyssinus proteins? J Allergy Clin Immunol 139:1030-1032.e1
Glesner, Jill; Vailes, Lisa D; Schlachter, Caleb et al. (2017) Antigenic Determinants of Der p 1: Specificity and Cross-Reactivity Associated with IgE Antibody Recognition. J Immunol 198:1334-1344
Woodfolk, Judith A; Glesner, Jill; Wright, Paul W et al. (2016) Antigenic Determinants of the Bilobal Cockroach Allergen Bla g 2. J Biol Chem 291:2288-301
Offermann, Lesa R; Schlachter, Caleb R; Perdue, Makenzie L et al. (2016) Structural, Functional, and Immunological Characterization of Profilin Panallergens Amb a 8, Art v 4, and Bet v 2. J Biol Chem 291:15447-59
Mueller, G A; Randall, T A; Glesner, J et al. (2016) Serological, genomic and structural analyses of the major mite allergen Der p 23. Clin Exp Allergy 46:365-76
Pomés, Anna; Chapman, Martin D; Wünschmann, Sabina (2016) Indoor Allergens and Allergic Respiratory Disease. Curr Allergy Asthma Rep 16:43
Pomés, Anna; Chruszcz, Maksymilian; Gustchina, Alla et al. (2015) 100 Years later: Celebrating the contributions of x-ray crystallography to allergy and clinical immunology. J Allergy Clin Immunol 136:29-37.e10
Chapman, Martin D; Wuenschmann, Sabina; King, Eva et al. (2015) Erratum to: Technological Innovations for High-Throughput Approaches to In Vitro Allergy Diagnosis. Curr Allergy Asthma Rep 15:52
Pomés, Anna; Chruszcz, Maksymilian; Gustchina, Alla et al. (2015) Interfaces between allergen structure and diagnosis: know your epitopes. Curr Allergy Asthma Rep 15:506

Showing the most recent 10 out of 30 publications